CoChat

Therapeutics Targeting Mutant KRAS

Open access
Thein, Kyaw Z., Biter, Amadeo B., Hong, David S. · 2021 · Annual Review of Medicine
Cited by 72

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Aberrations in rat sarcoma (RAS) viral oncogene are the most prevalent and best-known genetic alterations identified in human cancers. Indeed, RAS drives tumorigenesis as one of the downstream effectors of EGFR activation, regulating cellular switches and functions and triggering intracellular signaling cascades such as the MAPK and PI3K pathways. Of the three RAS isoforms expressed in human cells, all of which were linked to tumorigenesis more than three decades ago, KRAS is the most frequently mutated. In particular, point mutations in KRAS codon 12 are present in up to 80% of KRAS-mutant malignancies. Unfortunately, there are no approved KRAS-targeted agents, despite decades of research and development. Recently, a revolutionary strategy to use covalent allosteric inhibitors that target a shallow pocket on the KRAS surface has provided new impetus for renewed drug development efforts, specifically against KRAS G12C. These inhibitors, such as AMG 510 and MRTX849, show promise in early-phase studies. Nevertheless, combination strategies that target resistance mechanisms have become vital in the war against KRAS-mutant tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1146/annurev-med-080819-033145

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Research works printed but not linked: 57

  1. 10.1073/pnas.79.16.4848 · DOI · Paper page
  2. 10.1126/science.6285471 · DOI · Paper page
  3. 10.1038/2041104b0 · DOI · Paper page
  4. 10.1038/298343a0 · DOI · Paper page
  5. Kirsten WH, 1970, Bibl. Haematol., 1970, 246
  6. 10.1038/297474a0 · DOI · Paper page
  7. 10.1096/fasebj.3.10.2666231 · DOI · Paper page
  8. 10.1038/bjc.2014.215 · DOI · Paper page
  9. 10.1177/1947601911411084 · DOI · Paper page
  10. 10.1038/nrc969 · DOI · Paper page
  11. 10.1016/0092-8674(90)90186-I · DOI · Paper page
  12. 10.1016/j.cllc.2012.09.007 · DOI · Paper page
  13. 10.1126/science.2406906 · DOI · Paper page
  14. 10.1016/j.ccell.2016.02.015 · DOI
  15. 10.1016/j.drudis.2016.08.002 · DOI
  16. 10.1073/pnas.1811360116 · DOI · Paper page
  17. 10.1038/s41467-018-05707-2 · DOI · Paper page
  18. 10.1111/j.1440-1827.2010.02580.x · DOI · Paper page
  19. 10.1200/JCO.2009.27.4365 · DOI · Paper page
  20. 10.1371/journal.pone.0033003 · DOI · Paper page
  21. 10.1016/j.ctrv.2008.11.005 · DOI · Paper page
  22. 10.1007/s00384-019-03344-9 · DOI · Paper page
  23. 10.1038/s41388-017-0105-z · DOI · Paper page
  24. 10.1586/17476348.2016.1115349 · DOI · Paper page
  25. 10.1038/nature11252 · DOI · Paper page
  26. 10.1038/onc.2015.375 · DOI · Paper page
  27. 10.1371/journal.pone.0227366 · DOI
  28. 10.3389/fonc.2019.01295 · DOI
  29. 10.1038/s41416-019-0704-2 · DOI
  30. 10.1158/1078-0432.CCR-19-0197 · DOI · Paper page
  31. 10.2174/1389557518666180801110342 · DOI
  32. 10.1007/s00018-017-2564-3 · DOI
  33. 10.1080/10409238.2018.1431606 · DOI · Paper page
  34. 10.1038/nature25439 · DOI · Paper page
  35. 10.1016/j.bmcl.2017.06.047 · DOI
  36. 10.1158/1078-0432.CCR-18-3399 · DOI · Paper page
  37. 10.1177/1087057107307226 · DOI · Paper page
  38. 10.1016/j.bmc.2015.11.043 · DOI · Paper page
  39. 10.1021/acs.jmedchem.9b00145 · DOI · Paper page
  40. 10.1182/blood-2006-05-024752 · DOI · Paper page
  41. 10.1172/JCI65764 · DOI · Paper page
  42. 10.1038/nchembio.612 · DOI · Paper page
  43. 10.1016/j.ccr.2014.03.011 · DOI · Paper page
  44. 10.1016/j.advenzreg.2006.01.004 · DOI · Paper page
  45. 10.1158/0008-5472.CAN-07-6656 · DOI · Paper page
  46. 10.1158/1541-7786.MCR-15-0506 · DOI · Paper page
  47. 10.1038/nm.1890 · DOI · Paper page
  48. 10.1111/jcmm.12618 · DOI · Paper page
  49. 10.1016/S0092-8674(00)80938-1 · DOI · Paper page
  50. 10.1038/nrc1691 · DOI · Paper page
  51. de Castro Carpeno J, 2013, Transl. Lung Cancer Res., 2, 142
  52. 10.1200/JCO.2018.36.15_suppl.9025 · DOI
  53. Cancer Discovery, 2019, Cancer Discov, 9, 988
  54. 10.1016/j.jtho.2019.08.412 · DOI
  55. Janne PA, 2019, A phase I clinical trial evaluating the pharmakokinetics (PK), safety, and clinical activity of MRTX849, a mutant-selective small molecule KRAS G12C inhibitor, in advanced solid tumors
  56. 10.1016/j.ctrv.2020.101974 · DOI · Paper page
  57. 10.1038/s12276-018-0202-2 · DOI · Paper page

Cited by

See all 72

Metadata

Authors
Thein, K. Z., Biter, A. B., & Hong, D. S.
Venue
Annual Review of Medicine
Published
2021-01-27
Volume
72
Issue
1
Pages
349-364
ISSN
  • 0066-4219 (ISSN-L)
  • 1545-326X
OpenAlex
W3096441797
Cited by
72
References
45
FWCI
0.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Therapeutics Targeting Mutant KRAS. https://app.cochat.ai/papers/10.1146/annurev-med-080819-033145
The paper
Thein, K. Z., Biter, A. B., & Hong, D. S. (2021). Therapeutics Targeting Mutant KRAS. Annual Review of Medicine. https://doi.org/10.1146/annurev-med-080819-033145

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.